PuSH - Publikationsserver des Helmholtz Zentrums München

Luo, J. ; Molbay, M. ; Chen, Y. ; Horvath, I. ; Kadletz, K. ; Kick, B.* ; Zhao, S. ; Al-Maskari, R. ; Singh, I. ; Ali, M. ; Bhatia, H.S. ; Minde, D.-P. ; Negwer, M. ; Höher, L. ; Calandra, G.M.* ; Groschup, B.* ; Su, J. ; Kimna, C. ; Rong, Z. ; Galensowske, N. ; Todorov, M.I. ; Jeridi, D. ; Ohn, T.-L. ; Roth, S.* ; Simats, A.* ; Singh, V.* ; Khalin, I.* ; Pan, C. ; Arus, B.A. ; Bruns, O.T. ; Zeidler, R. ; Liesz, A.* ; Protzer, U. ; Plesnila, N.* ; Ussar, S. ; Hellal, F. ; Paetzold, J.C. ; Elsner, M. ; Dietz, H.* ; Ertürk, A.

Nanocarrier imaging at single-cell resolution across entire mouse bodies with deep learning.

Nat. Biotechnol., DOI: 10.1038/s41587-024-02528-1 (2025)
Verlagsversion DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
Efficient and accurate nanocarrier development for targeted drug delivery is hindered by a lack of methods to analyze its cell-level biodistribution across whole organisms. Here we present Single Cell Precision Nanocarrier Identification (SCP-Nano), an integrated experimental and deep learning pipeline to comprehensively quantify the targeting of nanocarriers throughout the whole mouse body at single-cell resolution. SCP-Nano reveals the tissue distribution patterns of lipid nanoparticles (LNPs) after different injection routes at doses as low as 0.0005 mg kg-1-far below the detection limits of conventional whole body imaging techniques. We demonstrate that intramuscularly injected LNPs carrying SARS-CoV-2 spike mRNA reach heart tissue, leading to proteome changes, suggesting immune activation and blood vessel damage. SCP-Nano generalizes to various types of nanocarriers, including liposomes, polyplexes, DNA origami and adeno-associated viruses (AAVs), revealing that an AAV2 variant transduces adipocytes throughout the body. SCP-Nano enables comprehensive three-dimensional mapping of nanocarrier distribution throughout mouse bodies with high sensitivity and should accelerate the development of precise and safe nanocarrier-based therapeutics.
Impact Factor
Scopus SNIP
Altmetric
41.700
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Dna Origami; Protein Corona; Rna Delivery; Nanostructures; Receptor; Coreceptor; Interplay; Tissue
Sprache englisch
Veröffentlichungsjahr 2025
HGF-Berichtsjahr 2025
ISSN (print) / ISBN 1087-0156
e-ISSN 1546-1696
Zeitschrift Nature Biotechnology
Verlag Nature Publishing Group
Verlagsort New York, NY
Begutachtungsstatus Peer reviewed
Institut(e) Institute for Tissue Engineering and Regenerative Medicine (ITERM)
Adipocytes & Metabolism (ADM)
Institute of Virology (VIRO)
Helmholtz Pioneer Campus (HPC)
Institute of Structural Biology (STB)
Institute of Computational Biology (ICB)
POF Topic(s) 30205 - Bioengineering and Digital Health
30203 - Molecular Targets and Therapies
Forschungsfeld(er) Enabling and Novel Technologies
Helmholtz Diabetes Center
Immune Response and Infection
Pioneer Campus
PSP-Element(e) G-505800-001
G-507200-001
G-502700-003
G-510001-001
G-503010-001
G-502799-701
G-503800-001
Förderungen Vascular Dementia Research Foundation
China Scholarship Council
European Research Council
Turkish Ministry of Education
Helmholtz AI
BMBF (HIVacToGC)
Nomis Heart Atlas project grant (Nomis Foundation)
European Research Council Consolidator grant
German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung (BMBF)) within the NATON collaboration
DFG
Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy within the framework of the Munich Cluster for Systems Neurology
Scopus ID 85217244775
PubMed ID 39809933
Erfassungsdatum 2025-05-09